Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer
Clinical trial NCT02539719 · TERMINATED
Trial details
- NCT number
- NCT02539719
- Sponsor
- Stemcentrx
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2019-01-02
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.